Snowball logo
logo
KROS_logo

Keros Therapeutics, Inc

KROS โ€ข NASDAQ
$14.47+$0.15ย  (1.05%)
Start your journey to financial independence โœจ
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently asked questions

What sector does Keros Therapeutics, Inc (KROS) operate in?

Keros Therapeutics, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Keros Therapeutics, Inc (KROS) current stock price?

As of the latest data, Keros Therapeutics, Inc stock price is $14.47, with a previous close of $14.32. Keros Therapeutics, Inc gained $0.15 in the last trading session, representing a 1.05% increase.

What is Keros Therapeutics, Inc (KROS) current market capitalization?

Keros Therapeutics, Inc market cap is approximately 587.70 million.

What is Keros Therapeutics, Inc (KROS) Earnings Per Share (EPS)?

The trailing EPS is -$0.17, and the forward EPS is -$4.09.

What is Keros Therapeutics, Inc (KROS) EBITDA?

Keros Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 152.38 million.

Does Keros Therapeutics, Inc (KROS) pay dividends?

No. Keros Therapeutics, Inc does not pay a dividend.

How did Keros Therapeutics, Inc (KROS) perform in its most recent earnings report?

In the last report (March 31, 2025), Keros Therapeutics, Inc posted an EPS surprise of 48,166.67% and a revenue surprise of 272.93%.

What is Keros Therapeutics, Inc (KROS) beta (volatility) score?

Keros Therapeutics, Inc has a beta of 1.295, suggesting it is more volatile than the market.